Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1558 of 5804
-
New cancer drug combo shows promise in early trial
Disease control CompletedThis is an open-label, multisite Phase I dose escalation, safety, pharmacokinetics (PK) and pharmacodynamics (PD) trial of BNT152+153 in various solid tumor indications. The clinical trial will enroll patients with various solid tumors that are metastatic or unresectable for who…
Phase: PHASE1 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a simple test predict who will beat skin cancer with immunotherapy?
Knowledge-focused Recruiting nowThis is a non-interventional study to prospectively test a suite of predictive biomarker models of immunotherapy resistance in patients with melanoma, non-melanoma skin cancers and other solid tumours. The study will evaluate the documentation, processes, accuracy and utility of …
Sponsor: Melanoma Institute Australia • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:42 UTC
-
Phone app may rally bystanders to save heart attack victims
Knowledge-focused OngoingThis randomized controlled trial will evaluate whether use of the PulsePoint system increases bystander CPR or defibrillator use compared to standard dispatch procedures in patients who suffer non-traumatic, out-of-hospital cardiac arrest in a public location. Half of all suspect…
Phase: NA • Sponsor: Dr. Steven Brooks • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
New study tests skills training to help breast cancer survivors overcome Long-Term pain
Symptom relief CompletedThe purpose of this study is to compare the benefits of skills training and health education interventions designed specifically to increase the well-being of people with persistent pain after breast surgery for lobular carcinoma in situ (LCIS), ductal carcinoma in situ (DCIS), o…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New study prepares adults with down syndrome for Alzheimer's trials
Knowledge-focused Recruiting nowThe purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), between the ages of 25-55, into a trial ready cohort (TRC), and up to 550 participants in total including co-enrolled in the Alzheimer Biomarkers Consortium - D…
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Can a nerve drug restore function after prostate cancer surgery?
Symptom relief Recruiting nowTo evaluate the role of 4-aminopyridine (4-AP) on the course of recovery after peripheral nerve traction and/or crush injury. This study aims to test the hypothesis that 4-aminopyridine speeds the often slow and unpredictable recovery after peripheral nerve traction and/or crush …
Phase: PHASE2, PHASE3 • Sponsor: John Elfar • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Sound waves zapping liver tumors? new device tested in 24 patients
Disease control OngoingThis trial is a single arm, non-randomized prospective trial. The objective of this trial is to evaluate the efficacy and safety of the HistoSonics System for the treatment of primary or metastatic tumors located in the liver.
Phase: NA • Sponsor: HistoSonics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo aims to stop postpartum bleeding in bleeding disorder
Disease control CompletedThis is a single-center randomized phase III clinical trial, the VWD-Woman Trial, in which 20 pregnant subjects with von Willebrand disease (VWD), defined as VWF ristocetin co-factor activity (VWF:RCo) \<0.50 IU/ml (historic) and previous history of bleeding are enrolled. Subject…
Phase: PHASE3 • Sponsor: Nicoletta C Machin • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Freeze and fight: new combo tackles metastatic bladder cancer
Disease control CompletedThis research study is examining the effectiveness of pembrolizumab plus cryoablation or aveluma plus cryoablation on people with urothelial carcinoma, including bladder cancer, that has spread.
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Heated chemo showdown: one dose fits all or custom fit?
Disease control Recruiting nowPeritoneal carcinomatosis from advanced gastro-intestinal malignancy has historically been associated with poor overall survival (≤ 12 months) with few treatment options. Cytoreductive surgery (CRS), which involves removal of all macroscopic tumor nodules, combined with direct ad…
Phase: PHASE2 • Sponsor: Prakash Pandalai • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New combo therapy aims to slow liver and lung cancers
Disease control OngoingThis study is being done to look at how effective the drug, atezolizumab, with or without the drug bevacizumab, is for people with inoperable liver cancer or non-small lung cancer that has spread to the liver. This will be done by looking at the duration of time from starting the…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Childhood obesity linked to worse MS brain damage?
Knowledge-focused OngoingObesity is one possible contributor to severity of multiple sclerosis and progression of the disease. We already know that obesity is a risk determinant for acquiring MS, yet the impact of obesity on pediatric MS disease expression and course is unknown. This study will evaluate …
Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New radiation combo may let some rectal cancer patients skip surgery
Disease control OngoingThe rationale of this clinical trial is to assess the feasibility of selective non-operative management for locally advanced rectal cancer using dose-escalated ultra-fractionated short course radiation therapy interdigitated with chemotherapy. We believe delivering short course r…
Phase: PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Breath test could spot breast cancer without needles or scans
Diagnosis OngoingThe goal of this prospective observational study is to compare the exhaled breath profiles of patient with invasive breast cancer and control subjects in the perspective of a diagnostic application in oncology. The main question it aims to answer is whether the exhaled breath pr…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
Could a common diabetes drug protect arteries in type 1 diabetes?
Disease control OngoingVascular calcification (VC) is a complication frequently observed in elderly, in chronic kidney disease (CKD) and in diabetes (particularly in type 1 diabetes). VC is a dynamic pathophysiological process that causes cardiovascular morbidity and is an independent risk factor of ma…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New IV drug aims to jolt atrial fibrillation back to normal rhythm in minutes
Disease control OngoingThis Phase 2 study is a two-stage, serial cohort dose escalation and expansion study of a single 30-minute (IV) infusion of HBI-3000 for the conversion of patients with recent-onset atrial fibrillation (AF). Stage A is open label and all patients will receive HBI-3000. In each o…
Phase: PHASE2 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New CAR t cocktail aims to tackle Hard-to-Treat myeloma
Disease control TerminatedThis is a global, open-label, multi-arm, multi-cohort, multi-center, phase 1/2 study to determine the safety, tolerability, efficacy, PK of bb2121 in combination with other therapies in adult subjects with R/RMM. The following combinations will be * Arm A will test bb2121 in co…
Phase: PHASE1 • Sponsor: Celgene • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug combo aims to shrink Hard-to-Treat pancreatic and ovarian tumors
Disease control OngoingThis phase I trial identifies the best dose, possible benefits and/or side effects of gemcitabine in combination with elimusertib (BAY 1895344) in treating patients with pancreatic, ovarian, and other solid tumors that have spread to other places in the body (advanced). Gemcitabi…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New PET scan could outshine CT for kidney cancer staging
Diagnosis Recruiting nowThe primary research purpose is to evaluate the diagnostic efficacy of 68Ga-PSMA PET in metastatic lesions of locally advanced and advanced renal cell carcinoma, and to compare with that of enhanced CT. The second purpose is to evaluate whether 68Ga-PSMA PET can change the treatm…
Phase: NA • Sponsor: Xijing Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Could a better tDCS protocol lift depression?
Symptom relief CompletedIn this project, the efficacy of different tDCS protocols in major depression will be investigated. The tDCS protocols have already been investigated in humans, and results showed that stimulation intensity has a different effect on tDCS long-term aftereffects based on the human …
Phase: NA • Sponsor: The National Brain Mapping Laboratory (NBML) • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC